09.11.2011

Albemarle Executive Chairman Mark Rohr to Take Over at Celanese

Celanese Chairman and CEO David N. Weidman will be retiring in April 2012. The company's board of directors has appointed Mark C. Rohr as his successor. Rohr is currently the executive chairman of Albemarle's board. He will step down from that position on Feb. 1. more04.01.2011

Credit Suisse's John McNulty Expects Chemical Industry Revenue to Increase 7% in 2011

Shares of Dow Chemical and other industry rivals rallied on the first trading day of the year after a leading chemical analyst raised several price targets and posted bullish industry expectations for 2011. more04.11.2010

Celanese Advances Controlled-Release Science for the Pharmaceutical Industry

Celanese has announced that its subsidiary, Celanese EVA Performance Polymers, has launched VitalDose, a polymer-based excipient that facilitates drug makers' efforts to develop and commercialize novel controlled-release solutions. more30.07.2010

Celanese Posts Q2 Profit Surge, Boosts 2010 Forecast

Celanese Corp said on Thursday that second-quarter profit rose 50 percent as the improving economy continued to increase demand for its products, and the chemical maker raised its full-year outlook.
Net income rose to $160 million, or $1.01 per share, from $107 million, or 69 cents per share, a year earlier.
Excluding one-time items, the company posted profit of $1.12 per share. Revenue at the Dallas-based company rose 22 percent to $1.52 billion. Analysts expected $1.46 billion. more08.04.2010

Celanese and SABIC Announce Polyacetal Expansion in Middle East

Celanese Corporation and Saudi Basic Industries Corporation (SABIC) announced their National Methanol (Ibn Sina) joint venture will construct a 50,000 ton polyacetal (POM) production facility in Saudi Arabia. more10.02.2010

Celanese Profit Beats Street; Revenue Up 8%

Celanese posted a better-than-expected fourth-quarter profit as demand for its chemical products increased, pushing revenue higher. The company reported net income of $5 million, or 2 cents per share, compared with a year-earlier loss of $155 million, or $1.09 per share. Excluding one-time items, including restructuring charges, Celanese posted profit of 50 cents per share. Analysts expected earnings of 47 cents per share, according to Thomson Reuters I/B/E/S. Revenue rose 8 percent to $1.39 billion. Analysts expected $1.25 billion. more08.12.2009

Slowly But Surely: Short-Interviews with Hans Wijers, Steven Sterin, Patrick Jany, Curt Espeland, ...

Interview with Steven Serin, Celanese
How has 2009 been for your company from a financial standpoint? more01.07.2009

Celanese Completes Sale of PVOH Business

Celanese announced the sale completion of its Polyvinyl alcohol business to Sekisui Chemical for $173 million. more